SALT LAKE CITY, March 5, 2013 -- (Healthcare Sales & Marketing Network) -- Myriad Genetics, Inc. (MYGN) announced today that a study published in the Journal of Clinical Oncology demonstrated that its Prolaris test, which analyzes the expression level of 4...
Diagnostics, Urology, Oncology
Myriad Genetics, Prolaris test, prostate cancer

Abingworth and Third Point Join Existing Investors WALTHAM, Mass.--(Healthcare Sales & Marketing Network)--Avedro, Inc. announced today the completion of a $43 million Series D financing led by Abingworth along with a significant investment by Third Poi...
Devices, Ophthalmology, Venture Capital
Avedro, corneal crosslinking

Combines Best Features of Past Generations Into a Single Light-Weight and Low-Profile Design WARSAW, Ind., March 4, 2013 -- (Healthcare Sales & Marketing Network) -- Symmetry Medical Inc. (SMA), a leading global source of innovative medical device solut...
Devices, Surgery
Symmetry Surgical, Rotilt Ratchet, surgical retractor

MODIIN, Israel--(Healthcare Sales & Marketing Network)--Exalenz Bioscience (EXEN.TA), a developer of a unique medical device intended for the diagnostics and management of disease of the digestive tract and the liver, has reported today the appointment of ...
Devices, Diagnostics, Personnel
Exalenz Bioscience, BreathID

NEW YORK, March 4, 2013 -- (Healthcare Sales & Marketing Network) -- Intercept Pharmaceuticals, Inc. (ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat ch...
Biopharmaceuticals, Personnel
Intercept Pharmaceuticals, obeticholic acid

Major East Coast hospital reported a 74% reduction in the use of Cathflo when using Neutron, suggesting incorporating this breakthrough technology into clinical practice may help alleviate Cathflo supply pressures in the wake of backorders SAN CLEMENTE,...
Devices
ICU Medical, Neutron Needlefree Catheter, Cathflo, Activase

CAMPBELL, Calif., March 4, 2013 -- (Healthcare Sales & Marketing Network) -- The Radiosurgery Society® (RSS), a non-profit organization of medical professionals dedicated to advancing the science and clinical practice of stereotactic radiosurgery (SRS...
Devices, Oncology
Accuray, Elekta, Varian Medical Systems, radiosurgery, radiotherapy

CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Ironwood Pharmaceuticals, Inc. (IRWD) today announced the appointment of Edward Owens to its board of directors. Mr. Owens is a recently retired partner, portfolio manager and global industry analys...
Biopharmaceuticals, Personnel
Ironwood Pharmaceuticals, LINZESS, linaclotide

ALPHARETTA, Ga.--(Healthcare Sales & Marketing Network)--Clearside Biomedical, Inc., a privately held ophthalmic company developing and commercializing targeted therapeutics for the treatment of sight-threatening diseases, today announced the appointment o...
Biopharmaceuticals, Ophthalmology, Personnel
Clearside Biomedical

Conference Call to be Held on March 4, 2013 at 8:30 a.m. EST Combination Adds Rapidly Growing Minimally Invasive Spinal Decompression Technology and Large Surgeon User Base Baxano Shareholders Commit $15.3M in Concurrent Financing RALEIGH, N.C., M...
Devices, Neurosurgery, Orthopaedic, Mergers & Acquisitions
TranS1, Baxano, iO-Flex system, spinal decompression, iO-Tome system

New lap sponge with enhanced visibility designed to improve patient safety to be introduced at the AORN 60th Congress IRVINE, Calif., March 4, 2013 -- (Healthcare Sales & Marketing Network) -- SurgiCount Medical, Inc., the wholly-owned operating subsid...
Devices, Surgery
SurgiCount Medical, Patient Safety Technologies, SAFE-T Lap, Safety-Sponge

SAN DIEGO, March 4, 2013 -- (Healthcare Sales & Marketing Network) -- Trovagene, Inc. (NASDAQ: TROV), a developer of transrenal molecular diagnostics, today announced that Mark Erlander, Ph.D., has joined the company as chief scientific officer. Dr. Erla...
Diagnostics, Personnel
Trovagene, transrenal molecular testing

TUSTIN, Calif.--(Healthcare Sales & Marketing Network)--Cardiovascular Institute of the South (CIS) now offers its patients the most advanced cardiac ultrasound, thanks to its purchase of 10 AplioTM 500s from Toshiba America Medical Systems, Inc. This is t...
Devices, Radiology, Cardiology
Toshiba America Medical Systems, cardiac ultrasound, Aplio 500

Venture Management, LLC, Leads Investment in Innovative Medical Technology Company MADISON, Wis.--(Healthcare Sales & Marketing Network)--Swallow Solutions, LLC (Swallow Solutions), a life sciences company with a novel dysphagia treatment platform, anno...
Devices, Venture Capital
Swallow Solutions, dysphagia

Patients Treated with Kimberly-Clark's Cooled Radiofrequency System Experienced Durable Relief of Discogenic and Sacroiliac Joint Pain ROSWELL, Ga., March 1, 2013 -- (Healthcare Sales & Marketing Network) -- Kimberly-Clark today announced the publicati...
Devices, Orthopaedic
Kimberly-Clark, Cooled Radiofrequency

Clinical and commercial progress advance novel cell therapy in wound care COLUMBIA, Md.--(Healthcare Sales & Marketing Network)--Osiris Therapeutics, Inc. (OSIR), the leading company focused on developing and marketing stem cell products to treat seriou...
Devices, Regenerative Medicine, Wound Care, Distribution
Osiris Therapeutics, Grafix, BioSmart, stem cell, diabetic foot ulcer

BETHESDA, Md.--(Healthcare Sales & Marketing Network)--Sucampo Pharmaceuticals, Inc. (SCMP) (SPI) today announced it appointed Barbara A. Munder, senior advisor to Euromoney Institutional Investor PLC, and Maureen E. O’Connell, executive vice president, ch...
Biopharmaceuticals, Personnel
Sucampo Pharmaceuticals, prostones

ARLINGTON, Tenn.--(Healthcare Sales & Marketing Network)--Wright Medical Group, Inc. (WMGI) today announced that it has completed its acquisition of BioMimetic Therapeutics, Inc. The transaction combines BioMimetic’s breakthrough biologics platform and pip...
Devices, Orthopaedic, Mergers & Acquisitions
Wright Medical Group, BioMimetic Therapeutics, Augment Bone Graft

Name and ticker symbol changes effective March 11, 2013 SAN DIEGO, Feb. 28, 2013 -- (Healthcare Sales & Marketing Network) -- ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that, effective March 11, 2013, its corporate name will be &quo...
Biopharmaceuticals
ADVENTRX Pharmaceuticals, Mast Therapeutics

QIDP granted for ceftolozane/tazobactam in HABP/VABP and cUTI Fast track status provided for ceftolozane/tazobactam (CXA-201) in cIAI Fast track status provided for surotomycin (CB-315) in CDAD LEXINGTON, Mass.--(Healthcare Sales & Marketing Net...
Biopharmaceuticals, FDA
Cubist Pharmaceuticals, ceftolozane, tazobactam, antibiotic